Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:50 AM
Ignite Modification Date:
2025-12-24 @ 11:50 AM
NCT ID:
NCT03754361
Eligibility Criteria:
Inclusion Criteria:
* CKD(chronic kidney disease)-5 stage patient whose eGFR（CKD-EPI（chronic kidney disease-epidemiology collaboration））\<15 ml/min/1.73m2,occured uremic symptoms or volume overload need of renal replacement therapy(RRT) within 14 days .
* Prolonged RRT access is not available.
* No dialysis treatment was given within 1 months.
* The vital signs are stable and tolerable in peritoneal dialysis catheterization or central venous catheterization.
* Able to understand the whole process of the trial, voluntarily participate in and sign informed consent.
Exclusion Criteria:
* Maintenance RRT alraedy.
* Serious metabolic disorders ( hyperkalemia and acidosis) cause significant changes in electrocardiogram or other emergency indications to RRT within 24 hours.
* Hypertensive emergencies(diastolic blood pressure\>130mmHg)
* Severe respiratory, circulatory or hepatic failure requires instrumental support or vasoactive drugs to maintain vital signs.
* High catabolic state eg. severe inflammation or trauma
* Absolute contraindication of peritoneal dialysis such as recent abdominal surgery (\<1month), multiple abdominal surgeries.
* Absolute contraindication for hemodialysis such as hemodynamic instability (systolic blood pressure \<80mmHg).
* Pregnant.
* Expected to survive for less than 1 years.
* Plan for kidney transplantation within 3 months.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT03754361
Study Brief:
Protocol Section:
NCT03754361